SCHEMBL1070735

SCHEMBL1070735

CO[Si](CCCN(CCO)CCO)(OC)OC

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL495659 1.00 LMNA (0.33) LMNA
SCHEMBL964926 0.98 LMNA (0.32) LMNA
SCHEMBL17272690 0.98 LMNA (0.32) LMNA
SCHEMBL1070750 0.92 LMNA (0.41) LMNA
SCHEMBL1071815 0.91 LMNA (0.33) LMNA
SCHEMBL6300884 0.91 LCK (0.32)
SCHEMBL26922105 0.89 LMNA (0.32) LMNA
SCHEMBL56463 0.89 LMNA (0.39) LMNA
SCHEMBL24177733 0.88
SCHEMBL21285225 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4744686-A1 ZWITTERIONIC POLYMER AND USE THEREOF Shanghai Shashuo Co., Ltd. (CN) 2026-05-20 EP claimed
WO-2025011567-A1 ZWITTERIONIC POLYMER AND USE THEREOF 上海沙烁新材料有限公司 2025-01-16 WO claimed
US-20110111212-A1 Method of Applying An Anti-Corrosion And/Or Adhesion Promoting Coating To A Metal And Resulting Coated Metal MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2011-05-12 US claimed
US-7875318-B2 Hydrolyzing partially or completely hydrolyzed silane possessing one or more hydroxyl groups; bis-(hydroxyethyl)aminopropyltriethoxysilane; chromium free; nontoxic; environmentally friendly MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2011-01-25 US claimed
EP-2147041-A2 METHOD OF APPLYING AN ANTI-CORROSION AND/OR ADHESION PROMOTING COATING TO A METAL AND RESULTING COATED METAL Momentive Performance Materials Inc. (US) 2010-01-27 EP claimed
WO-2008133916-A2 METHOD OF APPLYING AN ANTI-CORROSION AND/OR ADHESION PROMOTING COATING TO A METAL AND RESULTING COATED METAL MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2008-11-06 WO claimed
US-20080268162-A1 Method of applying an anti-corrosion and/or adhesion promoting coating to a metal and resulting coated metal MOMENTIVE PERFORMANCE MATERIALS INC. 2008-10-30 US claimed
EP-4744686-A1 ZWITTERIONIC POLYMER AND USE THEREOF Shanghai Shashuo Co., Ltd. (CN) 2026-05-20 EP disclosed
EP-3782599-B1 DENTAL POLYMERIZABLE COMPOSITION BASED ON CONDENSED SILANES VOCO GMBH (DE) 2025-09-17 EP disclosed
WO-2025011567-A1 ZWITTERIONIC POLYMER AND USE THEREOF 上海沙烁新材料有限公司 2025-01-16 WO disclosed
US-11992538-B2 Polymerizable dental composition based on condensed silanes VOCO GMBH (DE) 2024-05-28 US disclosed
US-20230350305-A1 MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, AND MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND TREATMENT LIQUID FUJIFILM CORPORATION (JP) 2023-11-02 US disclosed
WO-2023140053-A1 SURFACE TREATMENT AGENT, TREATED MATERIAL HAVING COATING, AND METHOD FOR MANUFACTURING SAME 日本パーカライジング株式会社 2023-07-27 WO disclosed
EP-1492581-B1 POLYMER COATING FOR MEDICAL DEVICES CV THERAPEUTICS INC (US) 2006-12-20 EP disclosed
US-20060093771-A1 Polymer coating for medical devices CV THERAPEUTICS, INC. 2006-05-04 US disclosed
EP-1492581-A1 POLYMER COATING FOR MEDICAL DEVICES CV THERAPEUTICS, INC. (US) 2005-01-05 EP disclosed
US-20030219562-A1 Polymer coating for medical devices CV THERAPEUTICS, INC. 2003-11-27 US disclosed
WO-2003068289-A1 POLYMER COATING FOR MEDICAL DEVICES CV THERAPEUTICS, INC. (US) 2003-08-21 WO disclosed
US-4229228-A Coating composition AMERICAN OPTICAL CORPORATION (US) 1980-10-21 US disclosed
US-4173490-A Coating composition AMERICAN OPTICAL CORPORATION (US) 1979-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11992538-B2 Polymerizable dental composition based on condensed silanes NCAPH, RCC1, NCAPD2 LMNA 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.